To assess the role of STAT3 in tumorigenesis, FISS-10 and FISS-14 primary cells exhibiting consistent ICC and IHC patterns with their corresponding FISS cells in FFPE were treated with the STAT3 inhibitor LLL12. This evidence concerns the gene STAT3 and intrahepatic cholangiocarcinoma.